The interplay between epigenetic silencing, oncogenic KRas and HIF-1 regulatory pathways in control of BNIP3 expression in human colorectal cancer cells

References

Page 1

	Year	Citations
Pancreatic cancers require autophagy for tumor growth Shenghong Yang, Xiaoxu Wang, Gianmarco Contino, Genes & Development Cell AutophagyMitophagyOncologyPancreatic CancerChemoprevention Strategy	2011	1.4K
Altered Growth of Human Colon Cancer Cell Lines Disrupted at Activated Ki- <i>ras</i> Senji Shirasawa, Masanori Furuse, Nobuhiko Yokoyama, Science	1993	622
BNIP3 Heterodimerizes with Bcl-2/Bcl-XL and Induces Cell Death Independent of a Bcl-2 Homology 3 (BH3) Domain at Both Mitochondrial and Nonmitochondrial Sites Reena Ray, Chen Gao, Christine Vande Velde, Journal of Biological Chemistry	2000	347
Silencing of the Hypoxia-Inducible Cell Death Protein BNIP3 in Pancreatic Cancer Jiro Okami, Diane M. Simeone, Craig D. Logsdon Cancer Research	2004	241
PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a) Brooke M. Emerling, Frank Weinberg, Juinn-Lin Liu, Proceedings of the National Academy of Sciences GeneticsCancer BiologyPi3k PathwayTumor BiologyTranscriptional Regulation	2008	216
Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis Mert Erkan, Jörg Kleeff, Iréne Esposito, Oncogene Tumor BiologyOncologyPancreatic CancerMedicinePathology	2005	212
Regulation of DNA Methylation by the Ras Signaling Pathway A. Robert MacLeod, Julie Rouleau, Moshe Szyf Journal of Biological Chemistry	1995	185
Aberrant Methylation and Silencing of the<i>BNIP3</i>Gene in Colorectal and Gastric Cancer Masafumi MURAI, Minoru Toyota, Hiromu Suzuki, Clinical Cancer Research Epigenetic ChangeGeneticsPathologyBnip3 ExpressionEpigenetics	2005	156
Antagonism of E2F-1 regulated Bnip3 transcription by NF-κB is essential for basal cell survival James Shaw, Natalia Yurkova, Tong Zhang, Proceedings of the National Academy of Sciences	2008	95
MEK1/2 Inhibitors AS703026 and AZD6244 May Be Potential Therapies for <i>KRAS</i> Mutated Colorectal Cancer That Is Resistant to EGFR Monoclonal Antibody Therapy Juyong Yoon, Kyoung-Hwa Koo, Kang‐Yell Choi Cancer Research Tumor BiologyNovel TherapyMek1/2 Inhibitors As703026MedicineImmunology	2010	90

Page 1